Determination of T cell response against XBB variants in adults who received either monovalent wild-type inactivated whole virus or mRNA vaccine or bivalent WT/BA.4-5 COVID-19 mRNA vaccine as the additional booster
Receiving bivalent mRNA vaccine as the third booster is preferable to induce both T cell and antibody responses against XBB.
Authors
- Malik Peiris (ORCID: https://orcid.org/0000-0001-8217-5995)
- Chee Wah Tan (ORCID: https://orcid.org/0000-0001-9837-1413)
- Ka Chun Chong (ORCID: https://orcid.org/0000-0001-5610-1298)
- Kwun Cheung Ling
- Chris Ka Pun Mok (ORCID: https://orcid.org/0000-0002-0525-6772)
- Chunke Chen
- Yuanxin Sun (ORCID: https://orcid.org/0000-0003-2916-7763)
- David S.C. Hui (ORCID: https://orcid.org/0000-0003-4382-2445)
- Yun Sang Tang (ORCID: https://orcid.org/0000-0002-4873-8712)
- Karen Yiu
- Ken KP Chan
Institutions
- Department of Health (CN)
- National University of Singapore (SG)
- Chinese University of Hong Kong (HK)
- Hong Kong Science and Technology Parks Corporation (HK)
- Hong Kong Jockey Club (HK)
- University of Hong Kong (HK)
Publication Details
- Journal
- International Journal of Infectious Diseases
- Published
- 2024-10-18
- DOI
- https://doi.org/10.1016/j.ijid.2024.107271
- Citations
- 1
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- Ministry of Health -Singapore
- Research Grants Council, University Grants Committee
- Health and Medical Research Fund
- Basic and Applied Basic Research Foundation of Guangdong Province